Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study

Autor: Mateos, Maria-Victoria, Rodriguez Otero, Paula *, Koh, Youngil, Martinez-Lopez, Joaquin *, Parmar, Gurdeep *, Prince, H. Miles, Quach, Hang, Ribas, Paz *, Hermansen, Emil *, Hungria, Vania T.M., Besisik, Sevgi Kalayoglu *, Kim, Jin Seok *, Leleu, Xavier, Pečeliūnas, Valdas *, Schjesvold, Fredrik, Sevindik, Omur G. *, Lavrova, Tatiana *, Dubin, Franck *, Devisme, Christine *, Lepine, Lucie *, Macé, Sandrine *, Morisse, Mony *, Ghobrial, Irene
Zdroj: In Blood 15 November 2022 140 Supplement 1:7317-7319
Databáze: ScienceDirect